Tharimmune, Inc. Director Stock Option Grant

On August 4, 2025, Sanam Parikh, a director of Tharimmune, Inc., was granted 50,000 stock options. The options have an exercise price of $1.33 per share and expire on August 4, 2035. Half of the options (25,000) vested immediately on the grant date, while the remaining 25,000 will vest on August 4, 2026. Following this transaction, Parikh owns a total of 50,000 shares of Tharimmune's common stock through these options. The transaction was reported in a Form 4 filing with the SEC.